PROCURE SELECTS IMPAC AS PROVIDER OF ONCOLOGY INFORMATION SYSTEMS

PROCURE SELECTS IMPAC AS PROVIDER OF ONCOLOGY INFORMATION SYSTEMS

PRESS RELEASE	
Stockholm, Sweden, January 24, 2008

ProCure Treatment Centers, Inc (ProCure) has announced that it has selected
IMPAC Medical Systems (IMPAC), an Elekta Company, as a preferred provider of
oncology information systems (OIS) for its IBA-equipped proton beam therapy
centers. ProCure designs, builds and operates proton beam therapy centers in
partnership with local radiation oncologists and community hospitals. 

A key component of developing proton beam therapy centers is the staffing and
training of all the center's employees. ProCure will have IMPAC's MOSAIQ™ OIS
software installed at its training and development center (TDC) in Bloomington,
IN. IMPAC will provide training at the TDC for the staff of ProCure's
IBA-equipped proton therapy centers. 

“ProCure's training and development center will ensure that their staff is
highly trained, efficient and ready to provide the highest level of care when a
proton center opens,” said Stewart Pegrum, Global Business Manager Particle
Therapy, at Elekta. “The TDC is the first facility dedicated to training the
highly-skilled professionals needed for proton therapy. The availability of the
MOSAIQ OIS system at the TDC will enable ProCure to both train personnel, and to
optimize the therapy workflow of the ProCure treatment centers.”

Construction is underway on the Oklahoma ProCure Treatment Center in Oklahoma
City, Oklahoma and the facility is expected to begin treating patients in the
summer of 2009. The facility will utilize the MOSAIQ OIS software. 

ProCure currently has a second facility in development in Chicago's western
suburbs; a certificate of need application is before the Illinois Healthcare
Facilities Planning Board. If regulatory approvals are received by the spring of
2008, it is expected patients will be able to receive treatment by mid-2010.

The MOSAIQ software is currently deployed at the Francis Burr Proton Therapy
Center at Massachusetts General Hospital, MD Anderson, University of Florida
Proton Therapy Institute and the Midwest Proton Radiotherapy Institute. “The
IMPAC team brings significant expertise in proton therapy and radiation oncology
with their software solution and more importantly the associated service,” said
Niek Schreuder, Senior Vice President of Technology at ProCure Treatment
Centers. “Elekta and IMPAC share the ProCure vision of making the OIS the
central hub for all the therapy workflow, and together we can make this happen.
This will provide significant benefits to our physician partners, hospital
partners and their patients,” added Schreuder.






******



For further information, please contact:

Media inquiries: Michelle Lee, PR and Advertising Manager,
Tel: +1 770-670-2447, e-mail: michelle.lee@elekta.com

Investor inquiries: Peter Ejemyr, Group VP Corporate Communications
Tel: +46 733 611 000 (mobile), e-mail: peter.ejemyr@elekta.com

Global Marketing inquires: Peter J. Gaccione, Vice President, Global Marketing
Tel: + 1 770 670 2380, email: peter.gaccione@elekta.com

About Elekta

Elekta is an international medical technology group, providing oncologists,
radiation therapists, neurosurgeons and many other medical specialists with
state of the art tools to fight serious disease.

Elekta provides advanced clinical solutions, comprehensive management and
information systems as well as services for improved cancer care and management
of brain disorders. 

Elekta's systems and solutions are used in over 4,500 hospitals around the
world. Clinical and information management solutions include, among others,
Leksell Gamma Knife® for non-invasive treatment of brain disorders, Elekta
Axesse™ and Elekta Synergy® for stereotactic and image guided radiation therapy
and radiosurgery as well as the MOSAIQ™ suite of software for image-enabled EMR
and efficient management of clinical and patient data.

With over 2,000 employees globally, the corporate headquarter is located in
Stockholm, Sweden and the company is listed on the Nordic Exchange under the
ticker EKTAb. More information about Elekta can be found at www.elekta.com.